SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: CuttingEdge Bio who wrote (3451)2/14/2022 3:44:56 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
It was "sarcastic" note, but there is small concern...
12 w interval will have 3 injection past load (20, 32 and 44), outcome 4 weeks after last dose
16 weeks interval will have 2 injection past load (24 and 40), outcome 8 weeks after last dose!
With (probably???, or maybe not) option for PRN doses.

Wish, they were more focused on 16w intervals, and outcome 8w after last dose.